OrganiGram Holdings Inc. (OGI.TO)
CAD 1.58
(8.22%)
CAD 1.58
(8.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 298.45 Million CAD | -48.28% |
| 2022 | 577.1 Million CAD | 4.17% |
| 2021 | 554.01 Million CAD | 32.66% |
| 2020 | 417.62 Million CAD | -2.54% |
| 2019 | 428.52 Million CAD | 41.63% |
| 2018 | 302.56 Million CAD | 226.01% |
| 2017 | 92.8 Million CAD | 72.29% |
| 2016 | 53.86 Million CAD | 279.98% |
| 2015 | 14.17 Million CAD | 10030.36% |
| 2014 | 139.93 Thousand CAD | -58.45% |
| 2013 | 336.76 Thousand CAD | -32.84% |
| 2012 | 501.44 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 354.74 Million CAD | 6.92% |
| 2024 Q1 | 299.01 Million CAD | 0.19% |
| 2024 Q2 | 331.77 Million CAD | 10.96% |
| 2023 Q4 | 298.45 Million CAD | -14.36% |
| 2023 Q1 | 573.22 Million CAD | -0.67% |
| 2023 Q2 | 551.73 Million CAD | -3.75% |
| 2023 Q3 | 348.51 Million CAD | -36.83% |
| 2023 FY | 298.45 Million CAD | -48.28% |
| 2022 Q2 | 585.1 Million CAD | 7.29% |
| 2022 Q4 | 577.1 Million CAD | -1.11% |
| 2022 FY | 577.1 Million CAD | 4.17% |
| 2022 Q1 | 545.36 Million CAD | -1.56% |
| 2022 Q3 | 583.56 Million CAD | -0.26% |
| 2021 Q2 | 392.76 Million CAD | -17.03% |
| 2021 Q3 | 576.71 Million CAD | 46.83% |
| 2021 FY | 554.01 Million CAD | 32.66% |
| 2021 Q4 | 554.01 Million CAD | -3.94% |
| 2021 Q1 | 473.37 Million CAD | 13.35% |
| 2020 FY | 417.62 Million CAD | -2.54% |
| 2020 Q3 | 433.67 Million CAD | -13.66% |
| 2020 Q2 | 502.27 Million CAD | 6.98% |
| 2020 Q1 | 469.48 Million CAD | 9.56% |
| 2020 Q4 | 417.62 Million CAD | -3.7% |
| 2019 Q4 | 428.52 Million CAD | 0.13% |
| 2019 FY | 428.52 Million CAD | 41.63% |
| 2019 Q3 | 427.98 Million CAD | 13.78% |
| 2019 Q2 | 376.15 Million CAD | 2.04% |
| 2019 Q1 | 368.62 Million CAD | 21.83% |
| 2018 Q4 | 302.56 Million CAD | 11.19% |
| 2018 FY | 302.56 Million CAD | 226.01% |
| 2018 Q1 | 96.6 Million CAD | 4.1% |
| 2018 Q2 | 268.77 Million CAD | 178.21% |
| 2018 Q3 | 272.12 Million CAD | 1.25% |
| 2017 Q2 | 91.21 Million CAD | 59.81% |
| 2017 Q1 | 57.07 Million CAD | 5.96% |
| 2017 FY | 92.8 Million CAD | 72.29% |
| 2017 Q4 | 92.8 Million CAD | 3.84% |
| 2017 Q3 | 89.37 Million CAD | -2.02% |
| 2016 Q4 | 53.86 Million CAD | 149.82% |
| 2016 Q3 | 21.56 Million CAD | 4.5% |
| 2016 Q2 | 20.63 Million CAD | 6.55% |
| 2016 Q1 | 19.36 Million CAD | 36.61% |
| 2016 FY | 53.86 Million CAD | 279.98% |
| 2015 FY | 14.17 Million CAD | 10030.36% |
| 2015 Q4 | 14.17 Million CAD | 17.11% |
| 2015 Q3 | 12.1 Million CAD | 0.49% |
| 2015 Q2 | 12.04 Million CAD | 17.63% |
| 2015 Q1 | 10.24 Million CAD | 18.18% |
| 2014 Q1 | 145.12 Thousand CAD | -54.74% |
| 2014 Q4 | 8.66 Million CAD | 6092.49% |
| 2014 Q3 | 139.93 Thousand CAD | -3.39% |
| 2014 Q2 | 144.84 Thousand CAD | -0.19% |
| 2014 FY | 139.93 Thousand CAD | -58.45% |
| 2013 FY | 336.76 Thousand CAD | -32.84% |
| 2013 Q1 | 368.17 Thousand CAD | -13.4% |
| 2013 Q2 | 337.05 Thousand CAD | -8.45% |
| 2013 Q3 | 336.76 Thousand CAD | -0.09% |
| 2013 Q4 | 320.65 Thousand CAD | -4.78% |
| 2012 Q4 | 425.14 Thousand CAD | -15.22% |
| 2012 Q3 | 501.44 Thousand CAD | -8.19% |
| 2012 Q2 | 546.19 Thousand CAD | 64.81% |
| 2012 Q1 | 331.4 Thousand CAD | 0.0% |
| 2012 FY | 501.44 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | 64.413% |
| Avicanna Inc. | 21.97 Million CAD | -1258.398% |
| Avant Brands Inc. | 82.55 Million CAD | -261.536% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -713.218% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -1113.33% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 68.434% |
| MediPharm Labs Corp. | 63.93 Million CAD | -366.795% |
| Canopy Growth Corporation | 1.3 Billion CAD | 77.048% |
| Willow Biosciences Inc. | 6.67 Million CAD | -4372.576% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | -13.956% |